B cell function in the tumor microenvironment

SM Downs-Canner, J Meier, BG Vincent… - Annual review of …, 2022 - annualreviews.org
The tumor microenvironment (TME) is a heterogeneous, complex organization composed of
tumor, stroma, and endothelial cells that is characterized by cross talk between tumor and …

Immunosuppressive mechanisms of regulatory B cells

D Catalán, MA Mansilla, A Ferrier, L Soto… - Frontiers in …, 2021 - frontiersin.org
Regulatory B cells (Bregs) is a term that encompasses all B cells that act to suppress
immune responses. Bregs contribute to the maintenance of tolerance, limiting ongoing …

Interleukin-1β and cancer

C Rébé, F Ghiringhelli - Cancers, 2020 - mdpi.com
Within a tumor, IL-1β is produced and secreted by various cell types, such as immune cells,
fibroblasts, or cancer cells. The IL1B gene is induced after “priming” of the cells and a …

Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy

B Mirlekar - SAGE open medicine, 2022 - journals.sagepub.com
Cytokines play a critical role in regulating host immune response toward cancer and
determining the overall fate of tumorigenesis. The tumor microenvironment is dominated …

Regulatory B cells in cancer

D Michaud, CR Steward, B Mirlekar… - Immunological …, 2021 - Wiley Online Library
Tumorigenesis proceeds through discrete steps where acquisition of genetic lesions and
changes in the surrounding microenvironment combine to drive unrestricted neoplastic …

Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

L Wan, KT Lin, MA Rahman, Y Ishigami, Z Wang… - Cancer discovery, 2023 - AACR
Inflammation is strongly associated with pancreatic ductal adenocarcinoma (PDAC), a highly
lethal malignancy. Dysregulated RNA splicing factors have been widely reported in …

Barriers and opportunities in pancreatic cancer immunotherapy

Y Ju, D Xu, M Liao, Y Sun, W Bao, F Yao… - NPJ Precision …, 2024 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) presents a fatal clinical challenge characterized
by a dismal 5-year overall survival rate, primarily due to the lack of early diagnosis and …

Extracellular vesicles in pancreatic cancer progression and therapies

CH Chang, S Pauklin - Cell death & disease, 2021 - nature.com
Pancreatic cancer (PC) is one of the leading causes of cancer-related death worldwide due
to delayed diagnosis and limited treatments. More than 90% of all pancreatic cancers are …

The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions

CJ Herting, I Karpovsky, GB Lesinski - Cancer and Metastasis Reviews, 2021 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies and is
characterized by a unique tumor microenvironment (TME) consisting of an abundant stromal …

Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept

W Luo, T Wen, X Qu - Journal of Experimental & Clinical Cancer Research, 2024 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal solid tumors. The tumor
immune microenvironment (TIME) formed by interactions among cancer cells, immune cells …